Your browser doesn't support javascript.
loading
Hepatic and renal end-organ damage in the Fontan circulation: A report from the Australian and New Zealand Fontan Registry.
Wilson, Thomas G; d'Udekem, Yves; Winlaw, David S; Cordina, Rachael L; Celermajer, David S; Wheaton, Gavin R; Bullock, Andrew; Gentles, Thomas L; Weintraub, Robert G; Justo, Robert N; Grigg, Leeanne E; Radford, Dorothy J; Hardikar, Winita; Cheung, Michael; Cain, Timothy M; Rao, Padma; Alexander, Stephen I; Ayer, Julian; Verrall, Charlotte; Du Plessis, Karin; Chapman, Janina; Rice, Kathryn; Barry, Judith; Zannino, Diana; Iyengar, Ajay J.
Afiliação
  • Wilson TG; Heart Research Group, Murdoch Children's Research Institute, Melbourne, Australia; Department of Paediatrics, Faculty of Medicine, The University of Melbourne, Victoria, Australia.
  • d'Udekem Y; Heart Research Group, Murdoch Children's Research Institute, Melbourne, Australia; Department of Paediatrics, Faculty of Medicine, The University of Melbourne, Victoria, Australia; Department of Cardiac Surgery, The Royal Children's Hospital, Melbourne, Australia. Electronic address: yves.dudekem@rc
  • Winlaw DS; The Heart Centre for Children, The Children's Hospital at Westmead, Sydney, Australia; Department of Paediatrics, University of Sydney, Sydney, Australia.
  • Cordina RL; Department of Paediatrics, University of Sydney, Sydney, Australia; Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia.
  • Celermajer DS; Department of Paediatrics, University of Sydney, Sydney, Australia; Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia.
  • Wheaton GR; Department of Cardiology, Women's and Children's Hospital, Adelaide, Australia.
  • Bullock A; Children's Cardiac Centre, Princess Margaret Hospital for Children, Perth, Australia.
  • Gentles TL; Greenlane Paediatric and Congenital Cardiac Service, Starship Children's Hospital, Auckland, New Zealand.
  • Weintraub RG; Heart Research Group, Murdoch Children's Research Institute, Melbourne, Australia; Department of Paediatrics, Faculty of Medicine, The University of Melbourne, Victoria, Australia; Department of Cardiology, The Royal Children's Hospital, Melbourne, Australia.
  • Justo RN; Queensland Paediatric Cardiac Service, Lady Cilento Children's Hospital, Brisbane, Queensland, Australia.
  • Grigg LE; Department of Cardiology, The Royal Melbourne Hospital, Melbourne, Australia.
  • Radford DJ; Adult Congenital Heart Unit, The Prince Charles Hospital, Brisbane, Australia; Faculty of Medicine, University of Queensland, Brisbane, Australia.
  • Hardikar W; Department of Gastroenterology, The Royal Children's Hospital, Melbourne, Australia.
  • Cheung M; Heart Research Group, Murdoch Children's Research Institute, Melbourne, Australia; Department of Cardiology, The Royal Children's Hospital, Melbourne, Australia.
  • Cain TM; Medical Imaging Department, The Royal Children's Hospital, Melbourne, Australia.
  • Rao P; Medical Imaging Department, The Royal Children's Hospital, Melbourne, Australia.
  • Alexander SI; The Heart Centre for Children, The Children's Hospital at Westmead, Sydney, Australia.
  • Ayer J; The Heart Centre for Children, The Children's Hospital at Westmead, Sydney, Australia; Department of Paediatrics, University of Sydney, Sydney, Australia.
  • Verrall C; The Heart Centre for Children, The Children's Hospital at Westmead, Sydney, Australia.
  • Du Plessis K; Heart Research Group, Murdoch Children's Research Institute, Melbourne, Australia.
  • Chapman J; Heart Research Group, Murdoch Children's Research Institute, Melbourne, Australia.
  • Rice K; Greenlane Paediatric and Congenital Cardiac Service, Starship Children's Hospital, Auckland, New Zealand.
  • Barry J; Greenlane Paediatric and Congenital Cardiac Service, Starship Children's Hospital, Auckland, New Zealand.
  • Zannino D; Heart Research Group, Murdoch Children's Research Institute, Melbourne, Australia.
  • Iyengar AJ; Heart Research Group, Murdoch Children's Research Institute, Melbourne, Australia; Department of Paediatrics, Faculty of Medicine, The University of Melbourne, Victoria, Australia; Department of Cardiac Surgery, The Royal Children's Hospital, Melbourne, Australia.
Int J Cardiol ; 273: 100-107, 2018 Dec 15.
Article em En | MEDLINE | ID: mdl-30060970
ABSTRACT

BACKGROUND:

Hepatic and renal dysfunction have been observed in survivors of the Fontan procedure, however their incidence and associated factors remain poorly defined.

METHODS:

A total of 152 participants from a Registry of 1528 patients underwent abdominal ultrasound, transient elastography (FibroScan), serum fibrosis score (FibroTest), in vivo Tc-99m DTPA measurement of glomerular filtration rate (mGFR), and urine albumin-creatinine ratio (ACR).

RESULTS:

Mean age and time since Fontan were 19.8 ±â€¯9.3 and 14.1 ±â€¯7.6 years, respectively. Features suggestive of hepatic fibrosis were observed on ultrasound in 87/143 (61%) and no patient was diagnosed with hepatocellular carcinoma. FibroScan median kPa was ≥10 in 117/133 (88%), ≥15 in 75/133 (56%), and ≥20 in 41/133 (31%). Fifty-four patients (54/118, 46%) had a FibroTest score ≥0.49 (equivalent to ≥F2 fibrosis). FibroTest score correlated with FibroScan value (r = 0.24, p = 0.015) and ACR (r = 0.29, p = 0.002), and patients with ultrasound features of hepatic fibrosis had a higher FibroScan median kPa (19.5 vs 15.4, p = 0.002). Renal impairment was mild (mGFR 60-89 ml/min/1.73 m2) in 46/131 (35%) and moderate (mGFR 30-59 ml/min/1.73 m2) in 3/131 (2%). Microalbuminuria was detected in 52/139 participants (37%). By multivariable analysis, time since Fontan was associated with increased FibroScan median kPa (ß = 0.89, 95% CI 0.54-1.25, p = 0.002) and decreased mGFR (ß = -0.77, 95% CI -1.29-0.24, p = 0.005).

CONCLUSIONS:

In the second decade after Fontan hepatic and renal structure and function are abnormal in a significant number of patients close to 60% have ultrasonographic evidence of structural hepatic abnormalities, 46% have elevated serum hepatic fibrosis scores, and 57% have either reduced glomerular filtration rate or microalbuminuria. Hepatic and renal function should be monitored for potential impacts on outcomes after Fontan completion.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistema de Registros / Técnica de Fontan / Relatório de Pesquisa / Rim / Fígado Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male País/Região como assunto: Oceania Idioma: En Revista: Int J Cardiol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistema de Registros / Técnica de Fontan / Relatório de Pesquisa / Rim / Fígado Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans / Male País/Região como assunto: Oceania Idioma: En Revista: Int J Cardiol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Austrália